{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:02:17Z","timestamp":1789786937785,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jpba.2026.117725","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:43:07Z","timestamp":1788795787000},"page":"117725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dominant doubly charged ion enabling robust LC\u2013MS\/MS quantification of a novel small-molecule antibacterial drug Cefidelbaz in human plasma and its application to pharmacokinetic and protein binding studies"],"prefix":"10.1016","volume":"282","author":[{"given":"Chenxin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2280-0284","authenticated-orcid":false,"given":"Yijue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-0985","authenticated-orcid":false,"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117725_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12088-024-01439-8","article-title":"Headway in synthetic chemistry: a gateway for antimicrobial trojan horse strategy for drug repurposing against multi-drug resistant Pseudomonas aeruginosa","volume":"65","author":"Mangal","year":"2025","journal-title":"Indian. J. Microbiol."},{"key":"10.1016\/j.jpba.2026.117725_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.semdp.2019.04.011","article-title":"Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat","volume":"36","author":"Lutgring","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.jpba.2026.117725_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2026.117725_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.mcna.2025.01.003","article-title":"Management of Severe Infections: Multidrug-Resistant and Carbapenem-Resistant Gram-Negative Bacteria","volume":"109","author":"Perez","year":"2025","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.jpba.2026.117725_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44259-024-00053-4","article-title":"Siderophores as tools and treatments","volume":"2","author":"Gr\u00e4ff","year":"2024","journal-title":"NPJ Antimicrob. Resist."},{"key":"10.1016\/j.jpba.2026.117725_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02163-17","article-title":"Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects","volume":"62","author":"Saisho","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117725_bib7","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117725_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2026.117725_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/mas.21551","article-title":"A tutorial in small molecule identification via electrospray ionization-mass spectrometry: The practical art of structural elucidation","volume":"37","author":"De Vijlder","year":"2018","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.jpba.2026.117725_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mas.1280140304","article-title":"Multiply charged ions","volume":"14","author":"V\u00e9key","year":"1995","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.jpba.2026.117725_bib11","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/jac\/dkad223","article-title":"The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting","volume":"78","author":"Pai Mangalore","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2026.117725_bib12","article-title":"LC\u2013MS\/MS-based multiplex antibacterial platform for therapeutic drug monitoring in intensive care unit patients","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117725_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1039\/D2AY01276F","article-title":"A rapid, simple, high-performance liquid chromatography method for the clinical measurement of beta-lactam antibiotics in serum and interstitial fluid","volume":"15","author":"Riezk","year":"2023","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2026.117725_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120619","article-title":"A review of bioanalytical methods for the therapeutic drug monitoring of \u03b2-lactam antibiotics in critically ill patients: Evaluation of the approaches used to develop and validate quality attributes","volume":"210","author":"Caro","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2026.117725_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpba.2018.01.031","article-title":"Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC\u2013MS\/MS method","volume":"152","author":"Paal","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.17145\/jab.18.019","article-title":"Liquid Chromatography-Tandem Mass Spectrometry Assays for Therapeutic Drug Monitoring of Cefepime","volume":"4","author":"Moorthy","year":"2018","journal-title":"J. Appl. Bioanal."},{"key":"10.1016\/j.jpba.2026.117725_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmsacl.2022.11.001","article-title":"LC-MS\/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring","volume":"26","author":"Radovanovic","year":"2022","journal-title":"J. Mass. Spectrom. Adv. Clin. Lab."},{"key":"10.1016\/j.jpba.2026.117725_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/antibiotics12020213","article-title":"Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring","volume":"12","author":"Barone","year":"2023","journal-title":"Antibiot. (Basel)"},{"key":"10.1016\/j.jpba.2026.117725_bib19","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Harmonized Guideline M10: Bioanalytical Method Validation and Study Sample Analysis, 2022."},{"key":"10.1016\/j.jpba.2026.117725_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpba.2012.11.018","article-title":"A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds","volume":"75","author":"Wang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jchromb.2011.03.001","article-title":"Simultaneous determination of eight \u03b2-lactam antibiotics in human serum by liquid chromatography\u2013tandem mass spectrometry","volume":"879","author":"Ohmori","year":"2011","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2026.117725_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2017.03.009","article-title":"Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of \u03b2-lactam antibiotic concentration in human plasma","volume":"468","author":"Rigo-Bonnin","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2026.117725_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2017.09.014","article-title":"A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma","volume":"1065-1066","author":"Lefeuvre","year":"2017","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2026.117725_bib24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/ac00106a008","article-title":"Improved Collisionally Activated Dissociation Efficiency and Mass Resolution on a Triple Quadrupole Mass Spectrometer System","volume":"67","author":"Thomson","year":"1995","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117725_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/mas.20246","article-title":"Atmospheric pressure ion sources","volume":"28","author":"Covey","year":"2009","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.jpba.2026.117725_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/mas.20332","article-title":"Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography\u2013tandem mass spectrometry","volume":"30","author":"Niessen","year":"2011","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.jpba.2026.117725_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113899","article-title":"Development and validation of a simple and sensitive LC-MS\/MS method for quantification of ampicillin and sulbactam in human plasma and its application to a clinical pharmacokinetic study","volume":"196","author":"Nalbant","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jpba.2019.06.041","article-title":"Liquid chromatography\u2013tandem mass spectrometry for the simultaneous quantitation of enmetazobactam and cefepime in human plasma","volume":"174","author":"Mameli","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2026.124975","article-title":"Pharmacokinetic, tissue distribution, permeability, protein binding and stability studies of finerenone in SD rats using validated UPLC and LC-MS method","volume":"1274","author":"Rathaur","year":"2026","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2026.117725_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpba.2011.02.006","article-title":"A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril","volume":"55","author":"Wenlock","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpba.2005.10.031","article-title":"Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids","volume":"41","author":"Taylor","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117725_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4155\/bio-2021-0109","article-title":"Solid-phase microextraction for assessment of plasma protein binding, a complement to rapid equilibrium dialysis","volume":"13","author":"Ahmad","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2026.117725_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jala.2010.06.002","article-title":"Development and Validation of a Higher-Throughput Equilibrium Dialysis Assay for Plasma Protein Binding","volume":"16","author":"van Liempd","year":"2011","journal-title":"J. Lab. Autom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:31:41Z","timestamp":1789785101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":33,"alternative-id":["S0731708526003936"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117725","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant doubly charged ion enabling robust LC\u2013MS\/MS quantification of a novel small-molecule antibacterial drug Cefidelbaz in human plasma and its application to pharmacokinetic and protein binding studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117725"}}